Nicolas Bosc, Researcher at ELIXIR - EMBL, considers eTRANSAFE as a framework that allows preclinical, clinical and related data to be shared, and accessed in a single place

Alexander Amberg, Head of In Silico Toxicology at Sanofi, analyses his role in the project as an EFPIA representative

Niklas Blomberg, Director of ELIXIR, explains his involvement and collaborations in the project